System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Johannes Oldenburg, MD, PhD

Hematology — University Hospital Bonn, Germany

LeadR Profile

Prof Johannes Oldenburg, MD, PhD University Hospital Bonn Germany
833 ScienceLeadR Reputation 833

Unlock

Register Login
Network Map

Hematology

Subspecialties: Genetics - Biochemistry - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1999 - 2026
Source: PubMed

University of Bonn

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 158

Citations

Citations: 40 1st author: 18 Last author: 46 Unique author: 0

Main journals

Hamostaseologie 83
Res Pract Thromb Haemost 25
Haemophilia 10
Blood 8
Eur Urol Open Sci 2

Best Journals

N Engl J Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Decoding full-length factor VIII through the structural and functional lens of its B domain.
microscopy, atomic force, factor viii, furin, models, structural, microscopy		Blood Vessel Thromb Hemost20261
FRONTIER5: Safety and patient experience of a direct switch from emicizumab to denecimig (Mim8) in patients with haemophilia A with or without inhibitors.
injections, safety, hemophilia a, therapeutics, thrombosis		J Thromb Haemost20260
AI-enabled discovery and biochemical optimization of minibinders targeting cancer cell-surface proteins.
cells, biological science disciplines, neoplasms, membrane proteins		Nat Commun20261
Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories.
injections, hemorrhage, hemophilia a, history, prospective studies		TH Open20260
T2 Mapping MRI for Differentiation of Hemarthrosis and Nonhemorrhagic Joint Effusion in Patients with Hemophilia.
blood, radiology, hemophilia a, hemarthrosis		Radiology20260

Clinical Studies 21

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 3

By phase:

Phase 3 10
Phase 4 4
N/A 3
Phase 1 2
Phase 1/Phase 2 1
Phase 2 1

By status:

Recruiting 9
Completed 7
Unknown 3
Active not recruiting 1
Not yet recruiting 1

By type:

Interventional 18
Observational 3

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 3
multicentricup10 17

Main Topics

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People with Hemophilia A
2025-522435-33-00 — safety, hemophilia a, pharmacokinetics		Phase 3Recruiting2026
A Trial to Learn if REGV131 LNP1265 is Safe and Works to Help the Body Make Clotting Factor in Adult Patients with Hemophilia B
2023-507260-40-00 — factor ix, genes, hemophilia b, clustered regularly interspaced short palindromic repeats, safety, hemorrhage, hemophilia a, blood coagulation factors, therapeutics		Phase 1/Phase 2Recruiting2025
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in People With Hemophilia A
2025-522434-32-00 — factor viii, safety, hemophilia a, pharmacokinetics		Phase 3Recruiting2026
A research study looking at how different doses of study medicine (Inno8) work in the body of people with haemophilia A
2025-520490-38-00 — work, hemophilia a, research		Phase 1Not yet recruiting2025
Nuwiq Dosing and outcomes In the ManagEment of women girls with haemophilia A Needing FVIII treatment for Surgery an International Open label Non controlled study (NuDIMENSION)
2022-502061-17-00 — hemophilia a, therapeutics, women		Phase 4Recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS